Vanguard Group Inc Cor Medix Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,977,658 shares of CRMD stock, worth $45.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,977,658
Previous 4,325,545 8.04%
Holding current value
$45.1 Million
Previous $53.3 Million 10.65%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$10.07 - $14.83 $3.5 Million - $5.16 Million
-347,887 Reduced 8.04%
3,977,658 $47.6 Million
Q2 2025

Aug 11, 2025
BUY
$5.86 - $16.56 $3.98 Million - $11.2 Million
678,994 Added 18.62%
4,325,545 $53.3 Million
Q1 2025

May 09, 2025
BUY
$6.16 - $12.57 $1.65 Million - $3.37 Million
268,360 Added 7.94%
3,646,551 $22.5 Million
Q4 2024

Feb 11, 2025
BUY
$8.1 - $13.59 $2.51 Million - $4.21 Million
309,514 Added 10.09%
3,378,191 $27.4 Million
Q3 2024

Nov 13, 2024
BUY
$3.64 - $8.23 $604,775 - $1.37 Million
166,147 Added 5.72%
3,068,677 $24.8 Million
Q2 2024

Aug 13, 2024
SELL
$4.08 - $6.39 $104,676 - $163,941
-25,656 Reduced 0.88%
2,902,530 $12.6 Million
Q1 2024

May 10, 2024
BUY
$2.94 - $4.24 $302,381 - $436,088
102,851 Added 3.64%
2,928,186 $12.4 Million
Q4 2023

Feb 14, 2024
BUY
$3.0 - $4.01 $523,761 - $700,093
174,587 Added 6.59%
2,825,335 $10.6 Million
Q3 2023

Nov 14, 2023
BUY
$3.6 - $4.46 $350,823 - $434,631
97,451 Added 3.82%
2,650,748 $9.81 Million
Q2 2023

Aug 14, 2023
BUY
$3.94 - $5.8 $2.43 Million - $3.57 Million
615,536 Added 31.77%
2,553,297 $10.1 Million
Q1 2023

May 15, 2023
BUY
$3.22 - $4.61 $452,200 - $647,405
140,435 Added 7.81%
1,937,761 $8.02 Million
Q4 2022

Feb 10, 2023
BUY
$2.81 - $4.45 $2,304 - $3,649
820 Added 0.05%
1,797,326 $7.58 Million
Q3 2022

Nov 14, 2022
BUY
$2.82 - $7.52 $399,030 - $1.06 Million
141,500 Added 8.55%
1,796,506 $5.08 Million
Q2 2022

Aug 12, 2022
SELL
$2.73 - $5.61 $434,804 - $893,499
-159,269 Reduced 8.78%
1,655,006 $6.65 Million
Q1 2022

May 13, 2022
SELL
$3.83 - $6.24 $25,756 - $41,964
-6,725 Reduced 0.37%
1,814,275 $9.94 Million
Q4 2021

Feb 14, 2022
BUY
$4.47 - $5.56 $44,941 - $55,900
10,054 Added 0.56%
1,821,000 $8.29 Million
Q3 2021

Nov 12, 2021
BUY
$4.46 - $7.11 $315,857 - $503,530
70,820 Added 4.07%
1,810,946 $8.42 Million
Q2 2021

Aug 13, 2021
BUY
$6.05 - $10.09 $10.5 Million - $17.6 Million
1,740,126 New
1,740,126 $11.9 Million

Others Institutions Holding CRMD

# of Institutions
204
Shares Held
41.2M
Call Options Held
1.33M
Put Options Held
1.3M
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $467M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email